Michelle York Gocio, Vice President of Drug Development and Clinical Operations, is a seasoned veteran of the pharmaceutical and biotechnology industry, having served 36 years in full scale development. Beginning her clinical research career in the neurosciences while still in college, Gocio gradually expanded her interests and conducted trials in a wide variety of therapeutic indications, including pain, cancer pain, oncology, gastroenterology, ophthalmology, surgery, and antibiotic therapies. Her early work in the field of learning differences and ADD/ADHD is published in The Journal of Learning Disabilities. During her career, Gocio has served in all roles, CRA through Vice President, and all phases of the development process, I-IV, prior to assuming her current role.

Ms.Gocio attended Northwestern University in Evanston, Illinois and graduated from the University of Arkansas at Little Rock with a major in Psychology and a minor in Biology. Additionally, Gocio has achieved certification as a Six Sigma Black Belt through the American Society of Quality. She has expanded the use of these engineering principles to drug development process to ensure operational excellence at Lakewood-Amedex Inc.